A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it ...

This longtime UVA employee underwent three preventative surgeries at once to reduce her risk of breast and ovarian cancer linked to a BRCA1 mutation.

A new study isolated DNA from the tumours of 500 cats across 13 different tumour types and mapped the sequence of 1,000 genes often found mutated in human cancers.

A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

Is cancer genetic? Find out how genes, family history, and lifestyle all affect your cancer risk explained in simple.

Sarah Diepstraten receives funding from the National Health and Medical Research Council, Cure Cancer Australia and My Room Children's Cancer Charity. John (Eddie) La Marca receives funding from ...

OMAHA, Neb. (InvestigateTV) — A Nebraska nurse practitioner says a free genetic research study likely saved her life after she learned she carries a BRCA2 gene mutation, despite having little family ...

During National Cancer Prevention Month, a Los Angeles man explains why genetic testing for BRCA and other mutations matters for men and how action saves lives. Cunaplus_M.Faba Getty Images For most ...

Receiving a diagnosis of follicular thyroid cancer (FTC) marks the beginning of a complex journey, but it is one that most patients navigate with high success rates. This guide provides a detailed ...

New research indicates that a long-maligned menopausal treatment is safer than previously thought, showing that it doesn’t increase breast cancer risk in women with inherited mutations in the BRCA1 or ...

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Menopausal hormone therapy did not elevate risk for breast cancer among women with inherited BRCA ...

Germline pathogenic variants contribute to 15%-20% of ovarian cancer cases, with BRCA1/2 mutations accounting for 65%-85% of these cases. Disparities in genetic testing uptake exist across racial, ...